Fig. 2From: The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infectionsDistribution of plasma and urinary LL-37 levels among patients and control participants according to their clinical remarks (No UTI, Cystitis and Pyelonephritis). The cases with Pyelonephritis has a higher levels of LL-37 in both urine and plasma samplesBack to article page